These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 2766855)
1. Influence of environmental factors on the in vitro efficacy of ciprofloxacin against anaerobic bacteria. Thadepalli H; Bansal MB; Marshall R; Prabhala RH Chemotherapy; 1989; 35(3):153-9. PubMed ID: 2766855 [TBL] [Abstract][Full Text] [Related]
2. Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro. Bansal MB; Thadepalli H Antimicrob Agents Chemother; 1987 Apr; 31(4):619-21. PubMed ID: 3606066 [TBL] [Abstract][Full Text] [Related]
3. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria. Borobio MV; Perea EJ Antimicrob Agents Chemother; 1984 Mar; 25(3):342-3. PubMed ID: 6721466 [TBL] [Abstract][Full Text] [Related]
4. Is ciprofloxacin active against clinically important anaerobes? Watt B; Brown FV J Antimicrob Chemother; 1986 May; 17(5):605-13. PubMed ID: 2941400 [TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model. Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626 [TBL] [Abstract][Full Text] [Related]
6. In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis. Esposito S; Gupta A; Thadepalli H Drugs Exp Clin Res; 1987; 13(8):489-92. PubMed ID: 3428131 [TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of ciprofloxacin combined with flomoxef against Bacteroides fragilis, compared with that of ciprofloxacin combined with clindamycin. Kato K; Iwai S; Sato T; Harada T; Nakagawa Y; Iwanaga H; Ito Y; Takayama T J Infect Chemother; 2002 Jun; 8(2):190-3. PubMed ID: 12111577 [TBL] [Abstract][Full Text] [Related]